" class="no-js "lang="en-US"> Alira Health Archives - Medtech Alert
Wednesday, April 10, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Alira Health Accelerates Global Growth and Secures Additional $58M in Funding

Alira Health, a global healthcare advisory, clinical research and technology company, announced it secured an […]

Abzena, Alira Health and Oncodesign Launch DRIVE™-Biologics to Support Access to Specialist Services from Discovery to Clinical Development for Oncology and Inflammation

Abzena, a partner research organization for integrated services from discovery through to clinical and commercial […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more